Literature DB >> 23649044

Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line.

Jennifer J Parker1, Jennifer C Jones, Samuel Strober, Susan J Knox.   

Abstract

Radiation therapy is a widely used cancer treatment and pre-transplantation conditioning regimen that has the potential to influence anti-tumor and post-transplantation immune responses. Although conventionally fractionated radiation doses can suppress immune responses by depleting lymphocytes, single high doses of local tumor radiation can enhance immune responses. Using phospho-flow cytometry analysis of a human monocytic cell line, we identified novel radiation-induced changes in the phosphorylation state of NFκB family members known in other cell types to maintain and regulate immune function. These phosphorylation changes were p53 independent, but were strongly dependent upon ATM activation due to DNA damage. We found that radiation promotes the activation and APC functional maturation through phosphorylation of NFκB Essential Modulator (NEMO). Our results and the analytic methods are especially well suited to the study of functional changes in APC when radiation is used for immune modulation in clinical protocols.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649044      PMCID: PMC4045494          DOI: 10.1016/j.clim.2013.03.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  48 in total

Review 1.  Danger signals: SOS to the immune system.

Authors:  S Gallucci; P Matzinger
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

Review 2.  Dendritic cells resurrect antigens from dead cells.

Authors:  M Larsson; J F Fonteneau; N Bhardwaj
Journal:  Trends Immunol       Date:  2001-03       Impact factor: 16.687

Review 3.  Radiation-induced apoptosis.

Authors:  M Verheij; H Bartelink
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 4.  Dendritic cell activation by danger and antigen-specific T-cell signalling.

Authors:  A D McLellan; E B Bröcker; E Kämpgen
Journal:  Exp Dermatol       Date:  2000-10       Impact factor: 3.960

5.  Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.

Authors:  P K Chakravarty; A Alfieri; E K Thomas; V Beri; K E Tanaka; B Vikram; C Guha
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

6.  Effect of costimulation and the microenvironment on antigen presentation by leukemic cells.

Authors:  A G Buggins; N Lea; J Gäken; D Darling; F Farzaneh; G J Mufti; W J Hirst
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

7.  The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function.

Authors:  J S Passmore; P T Lukey; S R Ress
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

8.  Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells.

Authors:  K K Steinauer; I Gibbs; S Ning; J N French; J Armstrong; S J Knox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-09-01       Impact factor: 7.038

9.  Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.

Authors:  F Lan; D Zeng; M Higuchi; P Huie; J P Higgins; S Strober
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

10.  Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Ryuji Okuyama; Mary A Davis; Rong Sun; Joel Whitfield; Randall N Knibbs; Lloyd M Stoolman; Alfred E Chang
Journal:  J Immunother       Date:  2008-05       Impact factor: 4.456

View more
  15 in total

Review 1.  Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?

Authors:  Elisa Gobbini; Matteo Giaj Levra
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.

Authors:  Andrew B Sharabi; Phuoc T Tran; Michael Lim; Charles G Drake; Theodore L Deweese
Journal:  Oncology (Williston Park)       Date:  2015-05       Impact factor: 2.990

Review 3.  Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.

Authors:  C Alberti
Journal:  G Chir       Date:  2017 Sep-Oct

Review 4.  Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes.

Authors:  Kalpana Mujoo; Clayton R Hunt; Raj K Pandita; Mauro Ferrari; Sunil Krishnan; John P Cooke; Stephen Hahn; Tej K Pandita
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

Review 5.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

6.  Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.

Authors:  Andrew B Sharabi; Christopher J Nirschl; Christina M Kochel; Thomas R Nirschl; Brian J Francica; Esteban Velarde; Theodore L Deweese; Charles G Drake
Journal:  Cancer Immunol Res       Date:  2014-12-19       Impact factor: 11.151

7.  First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors.

Authors:  Sebastian Klein; Oana-Diana Persa; Cornelia Mauch; Ka-Won Noh; Roberto Pappesch; Svenja Wagener-Ryczek; Reinhard Buettner; Alexander Quaas; Doris Helbig
Journal:  Oncoimmunology       Date:  2019-09-20       Impact factor: 8.110

8.  Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination.

Authors:  Christopher M Jackson; Christina M Kochel; Christopher J Nirschl; Nicholas M Durham; Jacob Ruzevick; Angela Alme; Brian J Francica; Jimmy Elias; Andrew Daniels; Thomas W Dubensky; Peter Lauer; Dirk G Brockstedt; Emily G Baxi; Peter A Calabresi; Janis M Taube; Carlos A Pardo; Henry Brem; Drew M Pardoll; Michael Lim; Charles G Drake
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

Review 9.  Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies.

Authors:  Géraldine Genard; Stéphane Lucas; Carine Michiels
Journal:  Front Immunol       Date:  2017-07-14       Impact factor: 7.561

10.  Current clinical trials testing the combination of immunotherapy with radiotherapy.

Authors:  Josephine Kang; Sandra Demaria; Silvia Formenti
Journal:  J Immunother Cancer       Date:  2016-09-20       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.